methoxyhydroxyphenylglycol has been researched along with caffeine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakazawa, K; Tanaka, H | 1 |
| Charney, DS; Heninger, GR; Jatlow, PI | 1 |
| Fujii, K; Miyahara, H; Suzuki, H | 1 |
| Boulenger, JP; Jimerson, DC; Post, RM; Uhde, TW | 1 |
| Charney, DS; Galloway, MP; Heninger, GR | 1 |
| Gibson, CJ | 1 |
| Bianchi, R; Wong, RK; Young, SR | 1 |
| Lasater, EM; Vigh, J | 1 |
| Crunelli, V; Parri, HR | 1 |
| Goto, M; Kaji, K; Kakihara, S; Matsumoto, C; Nakamura, J; Ohmori, O; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
| Albasanz, JL; Iglesias, I; León, D; Martín, M; Ruíz, MA | 1 |
| Choi, YM; Chung, S; Kim, SH; Park, MK; Uhm, DY | 1 |
| Hori, H; Mitoma, M; Miyamoto, K; Nakamura, J; Sugita, A; Ueda, N; Umene, W; Yoshimura, R | 1 |
| Hoffman, AF; Kawamura, M; Laaris, N; Lupica, CR; Masino, SA | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and caffeine
| Article | Year |
|---|---|
Increased anxiogenic effects of caffeine in panic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Beverages; Blood Pressure; Caffeine; Emotions; Fear; Female; Food; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Placebos; Pulse; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
3 trial(s) available for methoxyhydroxyphenylglycol and caffeine
| Article | Year |
|---|---|
Increased anxiogenic effects of caffeine in panic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Beverages; Blood Pressure; Caffeine; Emotions; Fear; Female; Food; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Placebos; Pulse; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Caffeine: relationship to human anxiety, plasma MHPG and cortisol.
Topics: Anxiety; Caffeine; Glycols; Humans; Hydrocortisone; Methoxyhydroxyphenylglycol | 1984 |
Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients.
Topics: Adult; Aged; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cotinine; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Smoking; Tobacco Use Disorder; Treatment Outcome | 2007 |
11 other study(ies) available for methoxyhydroxyphenylglycol and caffeine
| Article | Year |
|---|---|
Maternal caffeine ingestion increases the tyrosine level in neonatal rat cerebrum.
Topics: Amino Acids; Animals; Animals, Newborn; Animals, Suckling; Brain; Caffeine; Female; Liver; Maternal-Fetal Exchange; Methoxyhydroxyphenylglycol; Organ Size; Pregnancy; Rats; Rats, Inbred Strains; Theophylline; Tyrosine | 1990 |
Comparison of the effects of caffeine and procaine on noradrenergic transmission in the guinea-pig mesenteric artery.
Topics: Animals; Caffeine; Cell Membrane; Evoked Potentials; Female; Guinea Pigs; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Methoxyhydroxyphenylglycol; Muscle, Smooth, Vascular; Neuromuscular Junction; Norepinephrine; Procaine; Synaptic Transmission | 1985 |
The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans.
Topics: Adult; Anxiety; Autonomic Nervous System; Behavior; Blood Pressure; Caffeine; Female; Glycols; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Posture; Time Factors; Wakefulness | 1984 |
Caffeine withdrawal elevates urinary MHPG excretion.
Topics: Caffeine; Humans; Methoxyhydroxyphenylglycol; Substance Withdrawal Syndrome | 1981 |
Group I mGluR activation causes voltage-dependent and -independent Ca2+ rises in hippocampal pyramidal cells.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Cycloleucine; Guinea Pigs; Hippocampus; In Vitro Techniques; Ion Channel Gating; Membrane Potentials; Methoxyhydroxyphenylglycol; Patch-Clamp Techniques; Pyramidal Cells; Receptors, Metabotropic Glutamate | 1999 |
Intracellular calcium release resulting from mGluR1 receptor activation modulates GABAA currents in wide-field retinal amacrine cells: a study with caffeine.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amacrine Cells; Animals; Anticoagulants; Bicuculline; Caffeine; Calcium; Calcium Channels; Carps; Cells, Cultured; Central Nervous System Stimulants; Chelating Agents; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Conductivity; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Extracellular Space; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Heparin; Immunohistochemistry; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Kainic Acid; Membrane Potentials; Methoxyhydroxyphenylglycol; Organophosphorus Compounds; Patch-Clamp Techniques; Receptors, Cytoplasmic and Nuclear; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Retina; Ryanodine | 2003 |
The role of Ca2+ in the generation of spontaneous astrocytic Ca2+ oscillations.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aniline Compounds; Animals; Animals, Newborn; Anti-Infective Agents, Local; Astrocytes; Boron Compounds; Caffeine; Calcium; Calcium Channel Agonists; Calcium Signaling; Dioxolanes; Drug Interactions; Enzyme Inhibitors; In Vitro Techniques; Methoxyhydroxyphenylglycol; Microscopy, Confocal; Patch-Clamp Techniques; Purines; Rats; Ryanodine; Thalamus; Thimerosal; Xanthenes | 2003 |
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catecholamines; Central Nervous System Stimulants; Cotinine; Cues; Cytochrome P-450 CYP2D6; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking | 2005 |
Effect of chronic gestational treatment with caffeine or theophylline on Group I metabotropic glutamate receptors in maternal and fetal brain.
Topics: Animals; Blotting, Western; Brain; Caffeine; Cell Membrane; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Glutamic Acid; GTP-Binding Protein alpha Subunits, Gq-G11; Guanosine 5'-O-(3-Thiotriphosphate); Isoenzymes; Methoxyhydroxyphenylglycol; Phosphodiesterase Inhibitors; Phospholipase C beta; Pregnancy; Prenatal Exposure Delayed Effects; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Tritium; Type C Phospholipases | 2005 |
Regional interaction of endoplasmic reticulum Ca2+ signals between soma and dendrites through rapid luminal Ca2+ diffusion.
Topics: Animals; Animals, Newborn; Caffeine; Calcium; Calcium Signaling; Central Nervous System Stimulants; Dendrites; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Endoplasmic Reticulum; Fluorescent Dyes; In Vitro Techniques; Methoxyhydroxyphenylglycol; Neurons; Photobleaching; Rats; Rats, Sprague-Dawley; Sepharose; Substantia Nigra | 2006 |
Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
Topics: Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Benzoxazines; Biophysics; CA1 Region, Hippocampal; Caffeine; Calcium Channel Blockers; Dronabinol; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Piperidines; Presynaptic Terminals; Propanolamines; Pyrazoles; Quinoxalines; Receptor, Adenosine A1; Receptor, Cannabinoid, CB1; Xanthines | 2010 |